Publications et communications de Etienne BAUDOUX

LégendeIndices bibliométriques liés à la revue (pour celles dont l'ISSN a été indiqué par l'auteur) IF = Impact factor Thomson ISI. Sont indiqués : IF de l’année de publication et IF de la dernière édition du JCR (latest), « ? » si pas encore connu d'ORBi ; « - »  si inexistant. IF5 : idem que IF mais pour une période de 5 ans (nouvel indice depuis 2009). Suite à la décision des recteurs francophones d'abandonner la souscription au JCR Impact Factor, les données IF et IF5 ne sont plus mises à jour à partir de 2015. L'indice "latest" correspond à l'indice 2014 de la revue, ou de la dernière année de présence de la revue dans le JCR. EigenF = EigenFactor (voir : http://www.eigenfactor.org/). Article Infl. = Article Influence : EigenFactor divisé par le nombre d’articles publiés dans cette revue. En savoir plus ? http://orbi.uliege.be/rpt#revIndices bibliométriques liés à l'article ORBi viewed = nombre total de visualisations de la référence sur ORBi (dont X en interne à l'ULiège). ORBi downloaded = nombre total de téléchargements du texte intégral via ORBi, y compris tirés à part. SCOPUS® = nombre de citations du document repérées par SCOPUS®. En savoir plus ? http://orbi.uliege.be/rpt#art(Avertissement : en fonction des disciplines, certains indicateurs bibliométriques peuvent ne pas se révéler pertinents)__________________________________ , , etc: texte intégral du document disponible en Open Access , , etc: texte intégral du document disponible en accès restreint Peer reviewed (vérifié par ORBi) : l'information est présente dans la base ORBi des périodiques

1. Thèses et mémoires

1.b. Thèses de doctorat

3. Articles dans des revues scientifiques avec peer reviewing

3.a. À portée internationale

En tant que premier ou dernier auteur

B. Calmels, E. Gautier, A. Magnani, E. Magrin, A. C. Mamez, A. Vaissié, I. Yakoub-Agha, and E. BAUDOUX. "Procédé de préparation, contrôles de qualité et spécifications des immunosélections CD34+ : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)." Bulletin du Cancer (octobre 7, 2020).
Peer reviewed (vérifié par ORBi)
ORBi viewed: 29 (2 ULiège) ; downloaded: 3 (3 ULiège) — SCOPUS®: 0
IF 2020: ?; latest: 0.706; IF5: 0.58 — EigenF 2020: ?; latest: 0.001 — Article Infl. 2020: ?; latest: 0.1
M. Jöris, K. Paulson, L. Foley, M. Duffy, S. Querol, S. Gomez, and E. BAUDOUX. "Worldwide survey on key indicators for public cord blood banking technologies: By the World Marrow DonorAssociation Cord Blood Working Group." Stem Cells Translational Medicine (octobre 2020).
Peer reviewed (vérifié par ORBi)
ORBi viewed: 46 (6 ULiège) ; downloaded: 3 (1 ULiège) — SCOPUS®: 0
IF 2020: ?; latest: 4.247; IF5: 5.028 — EigenF 2020: ?; latest: 0.008 — Article Infl. 2020: ?; latest: 1.5
F. Boulanger, V. Decot, G. Bulliard, B. Calmels, C. Giraud, M. N. Lacassagne, A. Magnani et al. "Modalités de préparation, cryopréservation, décongélation des cellules souches hématopoïétiques et précautions pour infusion au patient: recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)." Bulletin du Cancer (octobre 31, 2016).
Peer reviewed (vérifié par ORBi)
ORBi viewed: 100 (10 ULiège) ; downloaded: 15 (13 ULiège) — SCOPUS®: 3 (0 sans les autocitations)
IF 2016: ?; latest: 0.706; IF5: 0.58 — EigenF: — Article Infl.:
E. Baudoux, U. Margraff, A. Coenen, X. Jacobs, M. Deboutez, C. Lungu, and D. Sondag-Thull. "Hemovigilance: Clinical Tolerance of Solvent-Detergent Treated Plasma." Vox Sanguinis 74, Suppl 1 (1998): 237-9.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 38 (8 ULiège) ; downloaded: 0 — SCOPUS®: 23 (23 sans les autocitations)
IF 1998: 1.807; latest: 2.656; IF5: 2.727 — EigenF 1998: 0.006; latest: 0.007 — Article Infl. 1998: 0.4; latest: 0.9

En tant que co-auteur

J.-P. HAUZEUR, C. LECHANTEUR, E. BAUDOUX, V. De Maertelaer, S. Pather, R. Katz, M. Malaise, J. Ino, and Y. Beguin. "Did Osteoblastic Cell Therapy Improve the Prognosis of Prefracture Osteonecrosis of the Femoral Head? A Randomized, Controlled Trial." Clinical Orthopaedics and Related Research (in press).
Peer reviewed (vérifié par ORBi)
ORBi viewed: 33 (3 ULiège) ; downloaded: 4 (4 ULiège)
IF latest: 3.127; IF5: 3.477 — EigenF latest: 0.041 — Article Infl. latest: 1.3
J.-H. Dalle, E. BAUDOUX, S. Caillat-Zucman, F. Colledani, M. PEREIRA-MARTINS, B. Bruno, S. Nguyen, M. Robin, and M. T. Rubio. "Le développement des cellules CAR-T et autre thérapie génique : tout n’est pas si simple." Bulletin du Cancer 107, no. 4 (avril 2020): 408-409.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 49 (4 ULiège) ; downloaded: 4 (4 ULiège) — SCOPUS®: 0
IF 2020: ?; latest: 0.706; IF5: 0.58 — EigenF 2020: ?; latest: 0.001 — Article Infl. 2020: ?; latest: 0.1
P. ERPICUM, L. WEEKERS, O. DETRY, C. BONVOISIN, M.-H. DELBOUILLE, C. GREGOIRE, E. BAUDOUX et al. "Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study." Kidney International 95 (2019): 693-707.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 180 (58 ULiège) ; downloaded: 109 (24 ULiège) — SCOPUS®: 15 (13 sans les autocitations)
IF 2019: ?; latest: 7.683; IF5: 7.839 — EigenF 2019: ?; latest: 0.052 — Article Infl. 2019: ?; latest: 2.8
J. De Vos, E. BAUDOUX, J.-O. Bay, B. Calmels, A. Cras, J. El Cheikh, M.-A. Guerout-Verite et al. "Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)." Bulletin du Cancer (décembre 2018).
Peer reviewed (vérifié par ORBi)
ORBi viewed: 82 (4 ULiège) ; downloaded: 4 (4 ULiège) — SCOPUS®: 1 (1 sans les autocitations)
IF 2018: ?; latest: 0.706; IF5: 0.58 — EigenF 2018: ?; latest: 0.001 — Article Infl. 2018: ?; latest: 0.1
Y. de Jamblinne, E. BAUDOUX, C. Delo, and Y. Coppieters. "Influence de facteurs obstétricaux sur les caractéristiques des greffons de sang de cordon ombilical." Gynécologie Obstétrique et Fertilité 46 (août 2018): 639-644.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 56 (9 ULiège) ; downloaded: 5 (5 ULiège) — SCOPUS®: 2 (2 sans les autocitations)
IF 2018: ?; latest: 0.574; IF5: 0.604 — EigenF 2018: ?; latest: 0.001 — Article Infl. 2018: ?; latest: 0.1
J.-P. HAUZEUR, V. De Maertelaer, E. BAUDOUX, M. MALAISE, Y. Beguin, and V. Gangji. "Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial." International Orthopaedics 42 (2018): 1429-1435.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 282 (11 ULiège) ; downloaded: 341 (3 ULiège) — SCOPUS®: 21 (20 sans les autocitations)
IF 2018: ?; latest: 2.387; IF5: 2.481 — EigenF 2018: ?; latest: 0.017 — Article Infl. 2018: ?; latest: 0.7
S. Servais, F. Baron, C. LECHANTEUR, L. SEIDEL, D. Selleslag, J. Maertens, E. BAUDOUX et al. "Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graftversus- host disease: A multicenter prospective study." Oncotarget 9, no. 29 (2018): 20590-20604.
Peer reviewed
ORBi viewed: 37 (7 ULiège) ; downloaded: 2 (2 ULiège) — SCOPUS®: 7 (6 sans les autocitations)
IF 2018: ?; latest: 5.008; IF5: 5.415 — EigenF 2018: ?; latest: 0.031 — Article Infl. 2018: ?; latest: 1.4
O. DETRY, M. VANDERMEULEN, M.-H. DELBOUILLE, J. SOMJA, N. BLETARD, A. Briquet, C. LECHANTEUR et al. "Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study." Journal of Hepatology 67, no. 1 (juillet 2017): 47-55.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 181 (42 ULiège) ; downloaded: 154 (29 ULiège) — SCOPUS®: 42 (37 sans les autocitations)
IF 2017: ?; latest: 10.59; IF5: 10.548 — EigenF: — Article Infl.:
C. GREGOIRE, C. LECHANTEUR, A. BRIQUET, E. BAUDOUX, F. BARON, E. LOUIS, and Y. BEGUIN. "Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases." Alimentary Pharmacology and Therapeutics 45 (2017): 205-221.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 84 (28 ULiège) ; downloaded: 276 (14 ULiège) — SCOPUS®: 36 (35 sans les autocitations)
IF 2017: ?; latest: 6.32; IF5: 5.727 — EigenF 2017: ?; latest: 0.034 — Article Infl. 2017: ?; latest: 1.8
O. Nikolajeva, V. Rocha, R. Danby, A. Ruggeri, F. Volt, E. BAUDOUX, S. G. Gomez et al. "Umbilical Cord Blood Cytomegalovirus Serostatus Does Not Have an Impact on Outcomes of Umbilical Cord Blood Transplantation for Acute Leukemia." Biology of Blood and Marrow Transplantation (2017).
Peer reviewed (vérifié par ORBi)
ORBi viewed: 29 (5 ULiège) ; downloaded: 3 (2 ULiège) — SCOPUS®: 0
IF 2017: ?; latest: 3.98; IF5: 3.992 — EigenF 2017: ?; latest: 0.024 — Article Infl. 2017: ?; latest: 1.3
R. Saccardi, L. Tucunduva, A. Ruggeri, I. Ionescu, G. Koegler, S. Querol, G. Grazzini et al. "Impact of cord blood banking technologies on clinical outcome: a Eurocord/Cord Blood Committee (CTIWP), European Society for Blood and Marrow Transplantation and NetCord retrospective analysis." Transfusion 56, no. 8 (mai 31, 2016): 2021-2029.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 67 (16 ULiège) ; downloaded: 3 (3 ULiège) — SCOPUS®: 12 (9 sans les autocitations)
IF 2016: ?; latest: 3.042; IF5: 3.046 — EigenF 2016: ?; latest: 0.021 — Article Infl. 2016: ?; latest: 0.8
C. LECHANTEUR, A. BRIQUET, O. GIET, O. DELLOYE, E. BAUDOUX, and Y. BEGUIN. "Clinical - scale expansion of mesenchymal stromal cells: a large banking experience." Journal of Translational Medicine 14 (2016): 145-159.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 46 (7 ULiège) ; downloaded: 93 (1 ULiège) — SCOPUS®: 58 (52 sans les autocitations)
IF 2016: ?; latest: 3.694; IF5: 4.116 — EigenF: — Article Infl.:
H. Rouard, F. Boulanger, E. BAUDOUX, B. Calmels, J. de Vos, E. Gautier, M. N. Lacassagne et al. "Bone marrow processing for hematopoietic stem cell transplantation: recommendations of the SFGM-TC." Hématologie 21, Supp 3 (décembre 2015): 42-46.
Peer reviewed
ORBi viewed: 55 (15 ULiège) ; downloaded: 6 (5 ULiège) — SCOPUS®: 0
J. Pirnay, E. BAUDOUX, O. Cornu, A. Delforge, C. Delloye, J. Guns, E. Heinen et al. "Access to human tissues for research and product development." EMBO Reports 16, no. 5 (avril 7, 2015): 1-6.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 115 (14 ULiège) ; downloaded: 8 (6 ULiège) — SCOPUS®: 11 (9 sans les autocitations)
IF 2015: 7.739; latest: 7.739; IF5: 7.413 — EigenF 2015: 0.030; latest: 0.030 — Article Infl. 2015: 3.6; latest: 3.6
S. Servais, E. BAUDOUX, B. Brichard, D. Bron, C. Debruyn, M. De Bruyère, D. De Hemptinne et al. "Circadian and circannual variations in cord blood hematopoietic cell composition." Haematologica 100, no. 1 (janvier 2015): 32-34.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 44 (13 ULiège) ; downloaded: 7 (7 ULiège) — SCOPUS®: 4 (4 sans les autocitations)
IF 2015: 6.671; latest: 6.671; IF5: 5.877 — EigenF 2015: 0.042; latest: 0.042 — Article Infl. 2015: 2.2; latest: 2.2
M. Binsfeld, M. HANNON, E. Otjacques, S. Humblet-Baron, E. BAUDOUX, Y. BEGUIN, F. BARON, and J. CAERS. "Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation." Cancer Immunology, Immunotherapy 64 (2015): 989-998.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 51 (8 ULiège) ; downloaded: 1 (1 ULiège) — SCOPUS®: 1 (1 sans les autocitations)
IF 2015: 4.846; latest: 4.846; IF5: 4.011 — EigenF 2015: ?; latest: 0.015 — Article Infl. 2015: ?; latest: 1.1
R. Saccardi, C. Azqueta, C. Ballerini, L. Ballerini, E. BAUDOUX, R. Caporale, S. Dal Pozzo et al. "Modification of standard ISHAGE methodology for CD34+ cells count on thawed Cord Blood Units: results from a multi-center Eurocord/Netcord study." Bone Marrow Transplantation 50 (2015): 562.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 80 (5 ULiège) ; downloaded: 6 (3 ULiège) — SCOPUS®: -
IF 2015: 3.636; latest: 3.636; IF5: 3.513 — EigenF 2015: ?; latest: 0.017 — Article Infl. 2015: ?; latest: 1.0
R. SACCARDI, C. AZQUETA, L. BALLERINI, E. BAUDOUX, S. DAL POZZO, S. GOMEZ, G. KOGLER et al. "Flow Cytometry Assessment of CD34+ Viability in Thawed Cord Blood Units: A Multi-Center Eurocord and Netcord Study." Blood 124 (décembre 6, 2014).
Peer reviewed (vérifié par ORBi)
ORBi viewed: 110 (5 ULiège) ; downloaded: 4 (4 ULiège) — SCOPUS®: -
IF 2014: 10.452; latest: 11.847; IF5: 10.235 — EigenF 2014: 0.373; latest: 0.373 — Article Infl. 2014: 3.6; latest: 3.6
A. RUGGERI, M. LABOPIN, M. P. SORMANI, G. SANZ, J. SANZ, F. VOLT, G. MICHEL et al. "Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen." Haematologica 99 (septembre 2014): 1509-1515.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 32 (2 ULiège) ; downloaded: 321 — SCOPUS®: 26 (18 sans les autocitations)
IF 2014: 5.814; latest: 6.671; IF5: 5.877 — EigenF 2014: 0.040; latest: 0.040 — Article Infl. 2014: 2.1; latest: 2.1
CALMELS, F. Boulanger, E. BAUDOUX, V. Decot, A. Fawaz, C. Giraud, B. Hivert, L. Garderet, N. Milpied, and Yakoub-Agha. "Modalités de conservation et de destruction des produits cellulaires cryopréservés : recommandations de la SFGM-TC." Pathologie Biologie 62, no. 3 (juillet 1, 2014).
Peer reviewed (vérifié par ORBi)
ORBi viewed: 48 (7 ULiège) ; downloaded: 156 — SCOPUS®: 5 (1 sans les autocitations)
IF 2014: 1.2; latest: 1.009; IF5: 1.364 — EigenF 2014: 0.002; latest: 0.002 — Article Infl. 2014: 0.3; latest: 0.3
J. De Vos, B. Birebent, C. Faucher, O. GIET, Y. Hicheri, C. Lemarie, E. BAUDOUX et al. "Contrôle de qualité des USP via segments attachés : recommandations de la SFGM-TC." Pathologie Biologie (juillet 1, 2014).
Peer reviewed (vérifié par ORBi)
ORBi viewed: 50 (7 ULiège) ; downloaded: 307 (2 ULiège) — SCOPUS®: 10 (8 sans les autocitations)
IF 2014: 1.2; latest: 1.009; IF5: 1.364 — EigenF 2014: 0.002; latest: 0.002 — Article Infl. 2014: 0.3; latest: 0.3
M. Hannon, C. LECHANTEUR, S. Lucas, J. Somja, L. Seidel, L. Belle, F. Bruck et al. "Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease." Transfusion 54, February (juin 17, 2014): 353-363.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 266 (44 ULiège) ; downloaded: 361 (14 ULiège) — SCOPUS®: 42 (27 sans les autocitations)
IF 2014: 3.225; latest: 3.042; IF5: 3.046 — EigenF 2014: 0.021; latest: 0.021 — Article Infl. 2014: 0.8; latest: 0.8
C. LECHANTEUR, S. Baila, M. E. Janssen, O. GIET, A. BRIQUET, E. BAUDOUX, and Y. Beguin. "Large-Scale Clinical Expansion of Mesenchymal Stem Cells in the GMP-Compliant, Closed Automated Quantum® Cell Expansion System: Comparison with Expansion in Traditional T-Flasks." Journal of Stem Cell Research and Therapy 4, no. 8 (2014): 1000222.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 469 (46 ULiège) ; downloaded: 586 (17 ULiège)
F. Baron, S. Humblet-Baron, G. Ehx, S. SERVAIS, M. HANNON, L. Belle, C. LECHANTEUR et al. "Thinking out of the box - New approaches to controlling GVHD." Current Hematologic Malignancy Reports 9 (2014): 73-84.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 174 (26 ULiège) ; downloaded: 296 (4 ULiège) — SCOPUS®: 4 (4 sans les autocitations)
IF 2014: 2.2; latest: 2.146; IF5: 1.964 — EigenF: — Article Infl.:
C. MOERMANS, C. LECHANTEUR, E. BAUDOUX, O. GIET, M. HENKET, L. SEIDEL, M. LEJEUNE et al. "Impact of cotransplantation of mesenchymal stem cells on lung function after unrelated allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning." Transplantation 98, no. 3 (2014): 348-353.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 96 (33 ULiège) ; downloaded: 184 (15 ULiège) — SCOPUS®: 12 (9 sans les autocitations)
IF 2014: 3.828; latest: 3.69; IF5: 3.446 — EigenF 2014: 0.038; latest: 0.038 — Article Infl. 2014: 1.2; latest: 1.2
J. Klykens, J. Pirnay, G. Verbeken, O. GIET, E. BAUDOUX, R. Jashari, A. Vanderkelen, and N. Ectors. "Cleanrooms and tissue banking how happy I could be with either GMP or GTP?" Cell and Tissue Banking (janvier 2013).
Peer reviewed (vérifié par ORBi)
ORBi viewed: 65 (6 ULiège) ; downloaded: 729 (5 ULiège) — SCOPUS®: 1 (1 sans les autocitations)
IF 2013: 1.026; latest: 1.248; IF5: 1.318 — EigenF 2013: 0.0015; latest: 0.001 — Article Infl. 2013: 0.3921; latest: 0.3
V. Rocha, S. Spellman, M. Zhang, A. Ruggeri, D. Purtill, C. Brady, L. Baxter-Lowe et al. "Effect of HLA-matching recipients to donor non-inherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy." Biology of Blood and Marrow Transplantation (décembre 2012).
Peer reviewed (vérifié par ORBi)
ORBi viewed: 38 (5 ULiège) ; downloaded: 792 (3 ULiège) — SCOPUS®: -
IF 2012: 3.94; latest: 3.98; IF5: 3.992 — EigenF 2012: 0.021; latest: 0.022 — Article Infl. 2012: 1.2; latest: 1.2
J. PIRNAY, N. ECTORS, C. DELLOYE, D. DUFRANE, E. BAUDOUX, M. VAN BRUSSEL, M. CASAER et al. "Beware of the commercialization of human cells and tissues: situation in the European Union." Cell and Tissue Banking (juin 21, 2012).
Peer reviewed (vérifié par ORBi)
ORBi viewed: 30 (8 ULiège) ; downloaded: 1 (1 ULiège) — SCOPUS®: 5 (3 sans les autocitations)
IF 2012: 1.171; latest: 1.248; IF5: 1.318 — EigenF 2012: 0.002; latest: 0.001 — Article Infl. 2012: 0.5; latest: 0.3
E. GLUCKMAN, V. ROCHA, E. BAUDOUX, M. BOO, J. KURTZBERG, K. WELTE, C. NAVARRETE, and S. VAN WALRAVEN. "Family-directed umbilical cord blood banking." Haematologica 96, no. 11 (juillet 12, 2011): 1700-17007.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 38 (3 ULiège) ; downloaded: 186 (1 ULiège) — SCOPUS®: 55 (43 sans les autocitations)
IF 2011: 6.424; latest: 6.671; IF5: 5.877 — EigenF 2011: 0.046; latest: 0.040 — Article Infl. 2011: 2.2; latest: 2.1
F. Baron, C. Lechanteur, E. Willems, F. Bruck, E. Baudoux, L. Seidel, J.-F. Vanbellinghen et al. "Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning." Biology of Blood and Marrow Transplantation 16, no. 6 (2010): 838-47.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 84 (33 ULiège) ; downloaded: 8 (6 ULiège) — SCOPUS®: 147 (131 sans les autocitations)
IF 2010: 3.275; latest: 3.98; IF5: 3.992 — EigenF 2010: 0.018; latest: 0.022 — Article Infl. 2010: 1.1; latest: 1.2
E. Willems* , F. Baron* , E. Baudoux, N. Wanten, L. Seidel, J.-F. Vanbellinghen, C. Herens et al. "Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial." Leukemia 23, no. 3 (2009): 608-10.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 116 (42 ULiège) ; downloaded: 127 (19 ULiège) — SCOPUS®: 8 (2 sans les autocitations)
IF 2009: 8.296; latest: 12.104; IF5: 9.85 — EigenF 2009: 0.059; latest: 0.057 — Article Infl. 2009: 2.4; latest: 3.4
* Ces auteurs ont contribué de façon équivalente à la publication.
A. Brand, P. Rebulla, C. P. Engelfriet, H. W. Reesink, Y. Beguin, E. Baudoux, G. Kögler et al. "Cord blood banking." Vox Sanguinis 95 (2008): 335-348.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 73 (3 ULiège) ; downloaded: 178 (4 ULiège) — SCOPUS®: 28 (18 sans les autocitations)
IF 2008: 2.755; latest: 2.656; IF5: 2.727 — EigenF 2008: 0.007; latest: 0.006 — Article Infl. 2008: 0.6; latest: 0.9
C. Bovy, E. Baudoux, J. Salmon, and Y. Beguin. "Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy." Transfusion 46, no. 9 (2006): 1616-23.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 53 ; downloaded: 101 — SCOPUS®: 3 (3 sans les autocitations)
IF 2006: 3.278; latest: 3.042; IF5: 3.046 — EigenF 2006: 0.020; latest: 0.021 — Article Infl. 2006: 0.7; latest: 0.8
F. Baron, S. Copizza, E. Baudoux, G. Jerusalem, G. Fillet, and Y. Beguin. "CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer." Haematologica 89, no. 9 (2004): 1146-8.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 36 (7 ULiège) ; downloaded: 2 — SCOPUS®: 3 (3 sans les autocitations)
IF 2004: 4.192; latest: 6.671; IF5: 5.877 — EigenF 2004: 0.016; latest: 0.040 — Article Infl. 2004: 0.8; latest: 2.1
F. Baron, P. Frere, E. Baudoux, B. Sautois, G. Fillet, and Y. Beguin. "Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma." Haematologica 88, no. 4 (2003): 478-80.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 34 (2 ULiège) ; downloaded: 108 (3 ULiège) — SCOPUS®: 11 (8 sans les autocitations)
IF 2003: 3.453; latest: 6.671; IF5: 5.877 — EigenF 2003: 0.015; latest: 0.040 — Article Infl. 2003: 0.7; latest: 2.1
F. Baron, P. Frere, E. Baudoux, N. Schaaf-Lafontaine, G. Fillet, and Y. Beguin. "Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update." Haematologica 88, no. 7 (2003): 835-7.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 31 (3 ULiège) ; downloaded: 58 (3 ULiège) — SCOPUS®: 9 (6 sans les autocitations)
IF 2003: 3.453; latest: 6.671; IF5: 5.877 — EigenF 2003: 0.015; latest: 0.040 — Article Infl. 2003: 0.7; latest: 2.1
F. Baron, N. Schaaf-Lafontaine, S. Humblet-Baron, N. Meuris, E. Castermans, E. Baudoux, P. Frere, V. Bours, G. Fillet, and Y. Beguin. "T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation." Transplantation 76, no. 12 (2003): 1705-13.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 120 (10 ULiège) ; downloaded: 225 (5 ULiège) — SCOPUS®: 23 (11 sans les autocitations)
IF 2003: 3.608; latest: 3.69; IF5: 3.446 — EigenF 2003: 0.093; latest: 0.038 — Article Infl. 2003: 1.1; latest: 1.2
F. Baron, E. Baudoux, P. Frere, S. Tourqui, N. Schaaf-Lafontaine, C. Herens, B. De Prijck, G. Fillet, and Y. Beguin. "Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC." Bone Marrow Transplantation 32, no. 8 (2003): 829-34.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 76 (6 ULiège) ; downloaded: 152 (2 ULiège) — SCOPUS®: 2 (1 sans les autocitations)
IF 2003: 2.172; latest: 3.636; IF5: 3.513 — EigenF 2003: 0.031; latest: 0.017 — Article Infl. 2003: 0.5; latest: 1.0
M. Andre, E. Baudoux, D. Bron, J.-L. Canon, V. D'Hondt, M.-F. Fassotte, L. D'Hondt et al. "Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies." Transfusion 43, no. 1 (2003): 50-7.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 159 (6 ULiège) ; downloaded: 19 — SCOPUS®: 45 (43 sans les autocitations)
IF 2003: 2.926; latest: 3.042; IF5: 3.046 — EigenF 2003: 0.016; latest: 0.021 — Article Infl. 2003: 0.6; latest: 0.8
F. Baron, E. Baudoux, G. Fillet, and Y. Beguin. "Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation." Hematology 7, no. 3 (2002): 137-43.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 32 (3 ULiège) ; downloaded: 96 (1 ULiège) — SCOPUS®: 2 (1 sans les autocitations)
IF 2002: -; latest: 1.385; IF5: 1.21 — EigenF 2002: -; latest: 0.002 — Article Infl. 2002: -; latest: 0.4
F. Baron, B. Sautois, E. Baudoux, G. Matus, G. Fillet, and Y. Beguin. "Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation." Experimental Hematology 30, no. 6 (2002): 546-54.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 60 (2 ULiège) ; downloaded: 135 (2 ULiège) — SCOPUS®: 28 (18 sans les autocitations)
IF 2002: 3.366; latest: 2.303; IF5: 2.356 — EigenF 2002: 0.021; latest: 0.009 — Article Infl. 2002: 1.0; latest: 1.0
F. Baron, J. Siquet, N. Schaaf-Lafontaine, E. Baudoux, J.-P. Hermanne, G. Fillet, and Y. Beguin. "Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation." Haematologica 87, no. 1 (2002): 78-88.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 35 (5 ULiège) ; downloaded: 68 (1 ULiège) — SCOPUS®: 16 (4 sans les autocitations)
IF 2002: 3.226; latest: 6.671; IF5: 5.877 — EigenF 2002: 0.012; latest: 0.040 — Article Infl. 2002: 0.5; latest: 2.1
F. Baron, E. Baudoux, P. Frere, S. Tourqui, N. Schaaf-Lafontaine, R. Greimers, C. Herens, G. Fillet, and Y. Beguin. "Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells." Journal of Hematotherapy and Stem Cell Research 11, no. 2 (2002): 301-14.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 45 (6 ULiège) ; downloaded: 114 (2 ULiège) — SCOPUS®: 24 (11 sans les autocitations)
IF 2002: 1.628; latest: -; IF5: - — EigenF: — Article Infl.:
C. P. Engelfriet, H. W. Reesink, J. E. Wagner, G. Kogler, V. Rocha, P. Wernet, L. Lecchi et al. "International forum. Use of umbilical cord blood progenitor cells as an alternative for bone marrow transplantation." Vox Sanguinis 83, no. 2 (2002): 172-87.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 44 ; downloaded: 34 — SCOPUS®: 5 (3 sans les autocitations)
IF 2002: 2.088; latest: 2.656; IF5: 2.727 — EigenF 2002: 0.007; latest: 0.006 — Article Infl. 2002: 0.5; latest: 0.9
B. Sautois, E. Baudoux, J. Salmon, S. Michaux, N. Schaaf-Lafontaine, M. Pereira-Martins, J.-M. Paulus, G. Fillet, and Y. Beguin. "Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation." Haematologica 86, no. 11 (2001): 1209-18.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 73 (4 ULiège) ; downloaded: 145 (2 ULiège) — SCOPUS®: 9 (6 sans les autocitations)
IF 2001: 3.216; latest: 6.671; IF5: 5.877 — EigenF 2001: 0.009; latest: 0.040 — Article Infl. 2001: 0.4; latest: 2.1
V. Fraipont, B. Sautois, E. Baudoux, M. Pereira-Martins, M.-F. Fassotte, J. P. Hermanne, G. Jerusalem et al. "Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF." Transfusion 40, no. 3 (2000): 339-47.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 92 (10 ULiège) ; downloaded: 10 (3 ULiège) — SCOPUS®: 17 (17 sans les autocitations)
IF 2000: 3.765; latest: 3.042; IF5: 3.046 — EigenF 2000: 0.017; latest: 0.021 — Article Infl. 2000: 0.8; latest: 0.8
J. Salmon, S. Michaux, J. P. Hermanne, E. Baudoux, C. Gerard, D. Sondag, G. Fillet, and Y. Beguin. "Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation." Transfusion 39, no. 8 (1999): 824-7.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 112 (5 ULiège) ; downloaded: 341 (1 ULiège) — SCOPUS®: 47 (47 sans les autocitations)
IF 1999: 3.77; latest: 3.042; IF5: 3.046 — EigenF 1999: 0.021; latest: 0.021 — Article Infl. 1999: 1.0; latest: 0.8
B. Sautois, V. Fraipont, E. Baudoux, M.-F. Fassotte, J. P. Hermanne, G. Jerusalem, V. Bours et al. "Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields." Haematologica 84, no. 4 (1999): 342-9.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 58 (10 ULiège) ; downloaded: 3 (2 ULiège) — SCOPUS®: 21 (16 sans les autocitations)
IF 1999: 2.074; latest: 6.671; IF5: 5.877 — EigenF 1999: 0.004; latest: 0.040 — Article Infl. 1999: 0.2; latest: 2.1
Y. Beguin, E. Baudoux, B. Sautois, V. Fraipont, N. Schaaf-Lafontaine, M. Pereira-Martins, J.-M. Paulus, D. Sondag, and G. Fillet. "Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells." Transfusion 38, no. 2 (1998): 199-208.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 61 (9 ULiège) — SCOPUS®: 25 (21 sans les autocitations)
IF 1998: 3.338; latest: 3.042; IF5: 3.046 — EigenF 1998: 0.017; latest: 0.023 — Article Infl. 1998: 0.8; latest: 0.9
M. Jacquet, V. LAMBERT, E. BAUDOUX, M. Muller, P. Kremers, and J. Gielen. "Correlation between P450 CYP1A1 Indelibility, MsPI Genotype and Lung Cancer Incidence." European Journal of Cancer 32A, no. 10 (avril 1996): 1701-1706.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 27 (3 ULiège) — SCOPUS®: -
IF 1996: 2.017; latest: 6.163; IF5: 5.626 — EigenF 1996: -; latest: 0.056 — Article Infl. 1996: -; latest: 1.9

3.b. À portée nationale

En tant que premier ou dernier auteur

E. Baudoux, F. Blaffart, C. Bouffioux, M. Caprasse, F. Courtois, M. R. Cremasco, E. De Pasqual et al. "La commission d'hemovigilance du CHU." Revue Médicale de Liège 55, no. 9 (2000): 878-80.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 281 (40 ULiège) ; downloaded: 258 (11 ULiège) — SCOPUS®: 0

En tant que co-auteur

S. SERVAIS, C. GREGOIRE, F. BARON, E. WILLEMS, A. BRIQUET, E. BAUDOUX, O. DELLOYE, O. GIET, C. LECHANTEUR, and Y. BEGUIN. "Multipotent mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation." Belgian Journal of Hematology 7 (2016): 229-235.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 51 (10 ULiège) ; downloaded: 96 (7 ULiège)
O. DETRY, F. JOURET, M. VANDERMEULEN, P. ERPICUM, L. Delens, C. GREGOIRE, A. BRIQUET et al. "Cellules stromales mésenchymateuses et transplantation d'organes." Revue Médicale de Liège 69 (décembre 2014): 53-56.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 159 (39 ULiège) ; downloaded: 236 (28 ULiège) — SCOPUS®: 1 (1 sans les autocitations)

4. Articles dans des revues scientifiques sans peer reviewing

4.a. À portée internationale

E. Baudoux. "Autologous Blood Donation Plus Epoetin Alfa in Nonanemic Orthopedic Surgery Patients." Seminars in Hematology 33, 2 Suppl 2 (avril 1996): 31-233.
ORBi viewed: 37 (15 ULiège) — SCOPUS®: 8 (8 sans les autocitations)
IF 1996: 2.44; latest: 4.438; IF5: 3.526 — EigenF 1996: -; latest: 0.004 — Article Infl. 1996: -; latest: 1.3

6. Chapitres et parties d’ouvrages collectifs

6.a. Chapitres

C. GREGOIRE, O. DETRY, F. Jouret, A. BRIQUET, C. LECHANTEUR, E. BAUDOUX, Y. Beguin, and O. GIET. "The use of mesenchymal stromal cells in solid organ transplantation." In The Biology and Therapeutic Application of Mesenchymal Cells. Hoboken, USA: John Willey & Sons, Inc, 2017. 825-835.
Peer reviewed
ORBi viewed: 169 (90 ULiège) ; downloaded: 196 (26 ULiège)
C. GREGOIRE, E. Louis, A. BRIQUET, C. LECHANTEUR, E. BAUDOUX, O. GIET, Y. Beguin, and F. BARON. "The role of mesenchymal stromal cells in the treatment of ulcerative colitis and Crohn’s disease." In The Biology and Therapeutic Application of Mesenchymal Cells. Hoboken, USA: John Wiley & Sons, Inc, 2017. 730-753.
Peer reviewed
ORBi viewed: 167 (81 ULiège) ; downloaded: 574 (21 ULiège)
J. Van Beckhoven, E. BAUDOUX, M. Duffy, H. Elmoazzen, N. Elwood, E. Gluckman, S. Gomez et al. "Cord Blood Banking: Cord blood management and evaluation: International networking." In A gift for life, WMDA handbook for blood stem cell donation. Edited by T. Bart, W. Hwang, and M. Boo. WMDA, 2013. 178-180.
ORBi viewed: 64 (1 ULiège) — SCOPUS®: -
E. Baudoux, M. Janssens, Y. Beguin, D. Sondag, G. Fillet, and M. Lamy. "Erythropoietin in surgery." In Proceedings of the 4th Regional Congress of the International Society of Blood Transfusion. 1993. 213-217.
ORBi viewed: 25 (4 ULiège) ; downloaded: 186 (6 ULiège) — SCOPUS®: -

9. Colloques et congrès scientifiques

9.a. Sur invitation

À portée internationale

E. BAUDOUX. "Sang de cordon état des lieux et perspectives." Paper presented at Congrès commun SFGM-TC 16e CONGRES et de la SFBCT 8e CONGRES. Liège, Belgique, novembre 16, 2016.
ORBi viewed: 32 (4 ULiège) ; downloaded: 39 (6 ULiège)
E. BAUDOUX, C. Lefebvre, and A. FASTH. "CORD DONOR Safety." Paper presented at International Donor Registry Conference 2014. London, United Kingdom, mai 16, 2014.
ORBi viewed: 109 (8 ULiège) ; downloaded: 73 (7 ULiège) — SCOPUS®: -
E. BAUDOUX. "Cord blood banking Introduction-State of the art." In World Cord blood congress IV and innovative therapies for sickle cell disease. Edited by E. Gluckman and Cavazzana. 2013.
ORBi viewed: 50 (6 ULiège) — SCOPUS®: -

9.b. Sur proposition personnelle

Publiées

À portée internationale
Avec peer reviewing
O. DETRY, M. VANDERMEULEN, M.-H. DELBOUILLE, J. SOMJA, N. BLETARD, A. BRIQUET, C. LECHANTEUR et al. "UNE INJECTION UNIQUE DE CELLULES STROMALES MESENCHYMATEUSES AU JOUR 3 APRES GREFFE HEPATIQUE EST INSUFFISANTE POUR INDUIRE UNE TOLERANCE OPERATIONNELLE." Transplant International 30, suppl 1 (janvier 2017): 812.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 54 (9 ULiège) ; downloaded: 46 (3 ULiège)
IF 2017: ?; latest: 2.835; IF5: 2.714 — EigenF: — Article Infl.:
J.-P. HAUZEUR, M. Tungouz, C. LECHANTEUR, Y. Beguin, E. BAUDOUX, V. de maertelaer, S. Pather et al. "Ostéoblastes autologues (PREOB®) versus concentré de moelle autologue dans l’ostéonécrose de la tête fémorale : étude randomisée." Revue de Chirurgie Orthopédique et Traumatologie 102 (octobre 2016): 73.
Peer reviewed
ORBi viewed: 74 (15 ULiège) ; downloaded: 11 (11 ULiège)
L. WEEKERS, P. Erpicum, O. DETRY, C. BONVOISIN, A. BRIQUET, C. LECHANTEUR, E. BAUDOUX, F. JOURET, and Y. BEGUIN. "administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up." Transplant International 29, Suppl 2 (2016): 13-6.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 52 (9 ULiège) ; downloaded: 21 (6 ULiège) — SCOPUS®: -
IF 2016: ?; latest: 2.835; IF5: 2.714 — EigenF 2016: ?; latest: 0.010 — Article Infl. 2016: ?; latest: 0.9
L. WEEKERS, P. ERPICUM, O. DETRY, F. JOURET, C. LECHANTEUR, M.-H. DELBOUILLE, A. BRIQUET, E. BAUDOUX, and Y. BEGUIN. "Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis." Transplant International 28, S4 (novembre 2015): 223-224278.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 66 (18 ULiège) ; downloaded: 63 (5 ULiège) — SCOPUS®: -
IF 2015: 2.835; latest: 2.835; IF5: 2.714 — EigenF 2015: ?; latest: 0.010 — Article Infl. 2015: ?; latest: 0.9
L. WEEKERS, P. ERPICUM, O. DETRY, C. LECHANTEUR, E. BAUDOUX, F. JOURET, and Y. BEGUIN. "Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis." American Journal of Transplantation 15, suppl 3 (mai 2015).
Peer reviewed (vérifié par ORBi)
ORBi viewed: 69 (16 ULiège) ; downloaded: 83 (7 ULiège) — SCOPUS®: -
IF 2015: 5.669; latest: 5.669; IF5: 5.637 — EigenF 2015: ?; latest: 0.053 — Article Infl. 2015: ?; latest: 2.0
R. SACCARDI, L. Tucunduva, A. Ruggeri, I. Ionescu, G. Koegler, S. Querol, L. Lecchi et al. "Effect of volume reduction of cord blood units before storage on transplantation outcomes: a retrospective analysis of Eurocord-EBMT and Netcord." Bone Marrow Transplantation 48 (avril 1, 2013): 34.
Peer reviewed (vérifié par ORBi)
ORBi viewed: 17 (3 ULiège) ; downloaded: 20 (1 ULiège) — SCOPUS®: -
IF 2013: 3.466; latest: 3.636; IF5: 3.513 — EigenF 2013: 0.018; latest: 0.017 — Article Infl. 2013: 1.0; latest: 1.0
À portée nationale
E. WILLEMS, E. CASTERMANS, F. Baron, E. BAUDOUX, N. Wanten, C. Bonnet, K. HAFRAOUI, P. Frère, G. Fillet, and Y. Beguin. "Nonmyeloablative stem cell transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a prospective randomized trial." Blood 106 (1075) (2005).
Peer reviewed (vérifié par ORBi)
ORBi viewed: 16 (7 ULiège) ; downloaded: 29 (3 ULiège) — SCOPUS®: -
IF 2005: 10.131; latest: 11.847; IF5: 10.235 — EigenF 2005: 0.465; latest: 0.373 — Article Infl. 2005: 3.1; latest: 3.6

Communications uniquement orales ou poster

À portée internationale
O. DETRY, M.-H. DELBOUILLE, C. LECHANTEUR, J. SOMJA, A. DE ROOVER, L. WEEKERS, J.-P. SQUIFFLET et al. "INFUSION OF THIRD-PARTY MESENCHYMAL STEM CELLS (MSC) AFTER KIDNEY AND LIVER TRANSPLANTATION: A PHASE I-II, OPEN-LABEL, CLINICAL STUDY (EudraCT 2011-001822-81 & NCT01429038)." Paper presented at 13eme rencontre de Beaune. Beaune, France, mai 30, 2013.
Peer reviewed
ORBi viewed: 99 (18 ULiège) ; downloaded: 126 (8 ULiège) — SCOPUS®: -
O. DETRY, M.-H. DELBOUILLE, C. LECHANTEUR, J. SOMJA, A. DE ROOVER, L. WEEKERS, P. DELVENNE, E. BAUDOUX, and Y. BEGUIN. "Infusion of third party mesenchymal stem cells (MSC) after kidney and liver transplantation: a phase I-II, open-label, clinical study." Paper presented at 4th Expert meeting. Barcelona, Spain, octobre 19, 2012.
Peer reviewed
ORBi viewed: 84 (10 ULiège) ; downloaded: 1 — SCOPUS®: -
F. Baron, E. WILLEMS, C. LECHANTEUR, E. BAUDOUX, P. Frere, J. Vanbellinghen, F. Bruck et al. "Co-transplantation of mesenchymal stem cells might mitigate acute GvHD without abrogating graftversus- tumour alloreactivity after allogeneic transplantation with non-myeloablative conditioning." Paper presented at 35th EBMT Annual Meeting, 2009.
Peer reviewed
ORBi viewed: 28 (3 ULiège) ; downloaded: 25 (2 ULiège) — SCOPUS®: -
E. WILLEMS, E. CASTERMANS, F. Baron, E. BAUDOUX, N. Wanten, C. Bonnet, K. HAFRAOUI, P. Frère, G. Fillet, and Y. Beguin. "Nonmyeloablative stem cell transplantation with CD8-depleted or unmalipulated peripheral blood stem cells: a prospective randomized trial." Paper presented at 21st General Meeting of the Belgian Hematological Society, 2006.
Peer reviewed
ORBi viewed: 18 (1 ULiège) ; downloaded: 2 — SCOPUS®: -
À portée nationale
L. WEEKERS, P. ERPICUM, O. DETRY, C. BONVOISIN, M.-H. DELBOUILLE, C. LECHANTEUR, A. BRIQUET, E. BAUDOUX, F. JOURET, and Y. BEGUIN. "Administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up." Paper presented at 24th Annual Meeting. Bruxelles, Belgium, mars 16, 2017.
Peer reviewed
ORBi viewed: 29 (6 ULiège) ; downloaded: 8 (3 ULiège)
P. Erpicum, L. WEEKERS, O. DETRY, C. BONVOISIN, C. LECHANTEUR, A. BRIQUET, E. BAUDOUX, F. JOURET, and Y. BEGUIN. "Administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up." Paper presented at Annual Meeting of the BVN-SBN. Bruxelles, Belgique, avril 28, 2016.
ORBi viewed: 39 (7 ULiège) ; downloaded: 17 (1 ULiège) — SCOPUS®: -
C. Grégoire, Y. Beguin, M. Hannon, S. DUBOIS, E. BAUDOUX, A. BRIQUET, C. LECHANTEUR, G. Ehx, and F. Baron. "Umbilical cord mesenchymal stromal cells are superior to bone marrow and adipose tissue-derived mesenchymal stromal cells for the treatment of xenogeneic graft-versus-host disease in mice." Paper presented at 31th General Meeting of the Belgian Hematological Society. La Hulpe, janvier 29, 2016.
Peer reviewed
ORBi viewed: 50 (12 ULiège) ; downloaded: 0 — SCOPUS®: -

11. Rapports

11.b. Rapports d'expertise

E. BAUDOUX, Y. BEGUIN, Y. Benoit, J. Billiet, A. Delforge, T. DEVOS, D. Latinne et al. "Cord blood for allogeneic use: Clinical and scientific aspects?" 8784. Bruxelles, Belgique: Conseil Supérieur de la Santé, 2012.
ORBi viewed: 20 (2 ULiège) — SCOPUS®: -
E. Angenon, E. BAUDOUX, Y. BEGUIN, Y. benoit, J. Billiet, A. Delforge, T. Devos et al. "Autologous cord blood use: Clinical and scientific aspects." 8677. 2011.
ORBi viewed: 19 (2 ULiège) — SCOPUS®: -

12. Documents pédagogiques

E. BAUDOUX, O. GIET, M. Jöris, C. Byam, V. Rocha, I. Ionescu, and H. Elmoazzen. "Importing and Exporting Cord Blood Units." 2016.
ORBi viewed: 24 (5 ULiège) ; downloaded: 1 (1 ULiège) — SCOPUS®: -
E. BAUDOUX. "Donor and stem cell source selection." Belgian Hematological Society, Donor and stem cell source selection. 2012.
ORBi viewed: 19 (4 ULiège) — SCOPUS®: -